Skip to main content
OpenTrials

Clinical trial condition

Haemophilia A

Explore clinical trials studying Haemophilia A. Study availability and eligibility vary by location and protocol.

78 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Haemophilia A trial results

Completed

Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects

NCT00840086

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Little Rock, Arkansas, United States
  • Novo Nordisk Investigational Site Long Beach, California, United States
  • Novo Nordisk Investigational Site Tampa, Florida, United States
  • Novo Nordisk Investigational Site Atlanta, Georgia, United States
View all 63 locations
View Trial Details
Completed

Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds

NCT00486278

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Augusta, Georgia, United States
  • Novo Nordisk Investigational Site Chicago, Illinois, United States
  • Novo Nordisk Investigational Site Indianapolis, Indiana, United States
View all 45 locations
View Trial Details
Completed

Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects

NCT00837356

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Berlin, Germany
  • Novo Nordisk Investigational Site Hanover, Germany
  • Novo Nordisk Investigational Site Tel Litwinsky, Israel
  • Novo Nordisk Investigational Site Florence, Italy
View Trial Details
Completed

Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A

NCT01692925

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Berlin, Germany
  • Novo Nordisk Investigational Site Frankfurt/M., Germany
  • Novo Nordisk Investigational Site Riga, Latvia
  • Novo Nordisk Investigational Site Kuala Lumpur, Malaysia
View Trial Details
Completed

Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A

NCT01205724

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Iowa City, Iowa, United States
  • Novo Nordisk Investigational Site Lexington, Kentucky, United States
  • Novo Nordisk Investigational Site Baltimore, Maryland, United States
  • Novo Nordisk Investigational Site Philadelphia, Pennsylvania, United States
View all 18 locations
View Trial Details
Completed

A Single Dose Trial of Recombinant Factor VIII (N8) in Japanese Subjects With Haemophilia A: An Extension to Trial NN7008-3543

NCT01238367

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Itabashi-ku, Tokyo, Japan
  • Novo Nordisk Investigational Site Kashihara-shi, Nara, Japan
  • Novo Nordisk Investigational Site Maebashi-shi, Gunma, Japan
  • Novo Nordisk Investigational Site Shinjuku-ku, Tokyo, Japan
View Trial Details

Related conditions